ArticleInternational journal of integrated care
New Model of Integrated Care for Patients with Immune-Mediated Inflammatory Diseases.
Article in International journal of integrated care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The complexity and transversality of the care for patients with immune-mediated inflammatory diseases (IMIDs) represents a challenge for the usual structure of health care services and requires a transformation of existing clinical management models. We describe the design, implementation and evaluation of a new collaborative care model for patients with IMIDs. Description: A group of multidisciplinary professionals including specialists from the rheumatology, gastroenterology, dermatology and pharmacy services designed and implemented an innovative health care model for patients with IMIDs that has changed the traditional model of care. One of the main challenges is the transversal leadership system in collaboration with all the hospital services involved, including the Medical Directorate of the hospital and patients, which promotes greater responsibility and empowerment. Discussion: Although IMID patient care by a multidisciplinary team is widely recommended, guidelines for IMID-specific models are lacking and few authors have reported controversial results of this strategy. Conclusions: CEIMI is a pioneering collaborative and multidisciplinary care model for patients with immune-mediated inflammatory diseases. This new model is integrated by physicians, pharmacists and specialised nurses and is oriented to meet the needs and expectations of the patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.